2017: Patent published in Indian patent journal (2017IN41045246).
2019: PCT Publication (WO2019/116110).
2019 YESHBIO SOLUTIONS PRIVATE LIMITED, (CIN: U85100TG2019PTC130502) an incorporated company in India and is recognized as a start-up by the Department for Promotion of Industry and Internal Trade. (DPIIT).
2019: YeshBio Solutions Pvt. Ltd. has been selected for Regional Presentation Round of the National Bio Entrepreneurship Competition (NBEC by BIRAC and CCAMP)2019.
2020: YeshBio Solutions selected for BIRAC boot camp training.
2021: YeshBio Solutions selected for Stanford Seed Spark.
2021: YeshBio Solutions ORA Patent granted in India.
2022: YeshBio Solutions Recognized as eligible business under section 80-IAC of the IT Act by Govt. of India.
2023: YeshBio Selected for AIC-T-Hub for Healthcare Startup Incubation.
2023: YeshBio have been selected for Atal Incubation Centre - CCMB-MeiTY TIDE-2.0,EIR grant
2024: New provisional Patent Application filed ( 202441014199)
2024: YeshBio is selected (2024) for the Entrepreneur in Residence (EIR) grant from AIC-CCMB (TIDE 2.0 and Cohort 4).
2025: YeshBio Patent Selected for PCT sponsored filing support (PCT/IN2025/050287) by ICRISAT IPFC.
2025: YeshBio’s filed Trademark’s (19) : GlucoregElite™, GlucoregElite™, Cardio Guard Elite™,Cardio Guard Elite ™(7056'178), Tension Guard ™, Tension Guard ™ (7056195), Uri guard™, Uri guard™ (7056200), Patient Guard ™, Patient Guard ™ (7056199), GoutGuard Elite™, GoutGuard Elite ™ (7056217), Cardio Guard ™, Cardlo Guard ™ (7056224), PatientGuard Elite ™, Patient Guard Elite ™ (7056216), BPGuard ™, StressGuard ™, StressGuard ™ (705622V) from ICRISAT's IPFC.